Introduction
Non-invasive strategies using liver stiffness measurement (LSM) and platelet count according to Baveno VII criteria are widely used to rule out high-risk varices (HRV) and reduce unnecessary endoscopy in patients with compensated advanced chronic liver disease (cACLD). We aimed to evaluate the performance of spleen stiffness measurement (SSM) and assess whether combining SSM with Baveno VII criteria could improve rule-out strategies for HRV.
Aims & Methods
In this prospective study, 195 patients with cACLD underwent same-day LSM and SSM using FibroScan 630 Expert, followed by upper gastrointestinal endoscopy. HRV were defined as varices requiring treatment (medium or large varices, or small varices with red wale signs). Baveno VII rule-out criteria were defined as LSM <20 kPa and platelet count >150×10⁹/L. The SSM rule-out threshold was set at ≤40 kPa based on previously validated cut-offs. Two combined strategies were evaluated: a conservative model requiring both criteria to be met to avoid endoscopy (Baveno AND SSM), and an expanded model requiring either criterion to be met (Baveno OR SSM). The primary outcome was endoscopy avoidance and missed HRV.
Results
Among 195 patients, the median age was 61 (18–85) years, and 117 (60.0%) were male. The most common etiology was HBV (n=59, 30.3%), followed by MASH (n=51, 26.2%). Overall, 64 patients (32.8%) had HRV. Patients with HRV had significantly lower platelet counts and higher LSM and SSM values (all p<0.001). SSM demonstrated the highest discriminative ability for HRV (AUROC 0.860, 95% CI 0.806–0.913), compared with LSM (0.694, 95% CI 0.613–0.775) and platelet count (0.702, 95% CI 0.620–0.783). Baveno VII criteria spared endoscopy in 45/195 patients (23.1%), with a sensitivity of 96.9% and NPV of 95.6%, missing 2/64 HRV cases (3.1%). SSM ≤40 kPa spared 78/195 patients (40.0%), with a sensitivity of 95.0% and NPV of 96.3%, missing 4/64 HRV cases (6.3%). The conservative combined strategy (Baveno AND SSM) spared endoscopy in 36/195 patients (18.5%), achieving 100% sensitivity and 100% NPV with no missed HRV cases (0%). In contrast, the expanded combined strategy (Baveno OR SSM) increased endoscopy sparing to 94/195 patients (48.2%), while maintaining high sensitivity (92.2%) and NPV (94.7%), at the cost of a higher HRV miss rate (5/64, 7.8%).
Conclusion
Incorporation of SSM into Baveno VII criteria refines non-invasive rule-out strategies for HRV. A conservative combined approach (Baveno AND SSM) ensures complete safety with no missed HRV, while an expanded approach (Baveno OR SSM) substantially increases endoscopy avoidance at the expense of a higher miss rate. These findings support the tailored use of SSM to optimize clinical decision-making in patients with cACLD.
References
1. de Franchis, R., Bosch, J., Garcia-Tsao, G., et al. Baveno VII - Renewing consensus in portal hypertension. Journal of hepatology, 2022, 76(4), 959–974.
2. Colecchia, A., Ravaioli, F., Marasco, G., et al. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease. Journal of hepatology, 2018, 69(2), 308–317.
3. Zhang, X., Song, J., Zhang, Y., et al. Baveno VII algorithm outperformed other models in ruling out high-risk varices in individuals with HBV-related cirrhosis. Journal of hepatology, 2023, 78(3), 574–583.
Disclosure
None